FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147526306> ?p ?o ?g. }

• W2147526306 endingPage "2413" @default.
• W2147526306 startingPage "2406" @default.
• W2147526306 abstract "microRNAs (miRNAs) are 21-22 nucleotide non-coding RNAs that regulate gene expression and play fundamental roles in biological processes. These small molecules bind to target mRNAs, leading to translational repression and/or mRNA degradation. Aberrant miRNA expression is associated with several human diseases such as cancer, cardiovascular disorders, inflammatory diseases and gynecological pathology. The present article reviews the role of miRNAs in four gynecological disorders that affect the ovary or the uterus, one benign and frequent disease (endometriosis) that is classified as a tumor-like lesion and three malignant gynecological diseases (endometrial, cervical and ovarian cancers). Endometriosis, defined as the presence of endometrium outside the uterus, is one of the most frequent benign gynecological diseases. Similarly to tumor metastasis, endometriotic implants require neovascularization to proliferate, invade the extracellular matrix and establish an endometriotic lesion. Despite its high prevalence and incapacitating symptoms, the exact pathogenic mechanism of endometriosis remains unsolved. A relationship between endometriosis and gynecological cancer, especially ovarian cancer, has been reported. Endometriosis is a multifactorial and polygenic disease, and emerging data provide evidence that a dysregulation of miRNA expression may be involved. miRNAs appear to be potent regulators of gene expression in endometriosis, raising the prospect of using miRNAs as biomarkers and therapeutic tools in this disease. In cancer, miRNAs have an important role as regulatory molecules, acting as oncogenes (oncomiRs) or tumor suppressors. Endometrial cancer is one of the most frequent gynecological malignancies in the developed countries. Cervical cancer, also one of the most common cancers in women, is associated with high-risk human papillomaviruses although this infection alone may not be enough to induce the malignant transformation. Ovarian cancer is the fifth leading cause of all cancer-related deaths among women. Over 80% of cases are diagnosed at an advanced stage, with a reduced five-year survival rate. Recent studies have shown that miRNAs are aberrantly expressed in different human cancer types, including endometrial, cervical and ovarian cancer, and that specific dysregulated miRNAs may act as biomarkers of patients’ outcome. Recently, miRNAs have been detected in serum and plasma, and circulating miRNA expression profiles have now been associated with a range of different tumor types. Their accessibility in peripheral blood and stability given the fact that miRNAs circulate confined within exosomes, make researchers foster hope in their role as emerging biomarkers of cancer and other disorders. The development of therapies that might block the expression or mimic the functions of miRNAs could represent new therapeutic strategies for any of the aforementioned gynecological disorders. Keywords: microRNA, gynecological disease, endometriosis, cancer, endometrial cancer, cervical cancer, ovarian cancer, gene regulation, biomarker, angiogenesis" @default.
• W2147526306 created "2016-06-24" @default.
• W2147526306 creator A5005132007 @default.
• W2147526306 creator A5007693230 @default.
• W2147526306 creator A5029685260 @default.
• W2147526306 creator A5041260468 @default.
• W2147526306 creator A5041953237 @default.
• W2147526306 creator A5068695724 @default.
• W2147526306 creator A5079018683 @default.
• W2147526306 date "2012-04-24" @default.
• W2147526306 modified "2023-10-09" @default.
• W2147526306 title "Role of microRNAs in Gynecological Pathology" @default.
• W2147526306 cites W2014946489 @default.
• W2147526306 doi "https://doi.org/10.2174/092986712800269362" @default.
• W2147526306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22455593" @default.
• W2147526306 hasPublicationYear "2012" @default.
• W2147526306 type Work @default.
• W2147526306 sameAs 2147526306 @default.
• W2147526306 citedByCount "80" @default.
• W2147526306 countsByYear W21475263062012 @default.
• W2147526306 countsByYear W21475263062013 @default.
• W2147526306 countsByYear W21475263062014 @default.
• W2147526306 countsByYear W21475263062015 @default.
• W2147526306 countsByYear W21475263062016 @default.
• W2147526306 countsByYear W21475263062017 @default.
• W2147526306 countsByYear W21475263062018 @default.
• W2147526306 countsByYear W21475263062019 @default.
• W2147526306 countsByYear W21475263062020 @default.
• W2147526306 countsByYear W21475263062021 @default.
• W2147526306 countsByYear W21475263062022 @default.
• W2147526306 countsByYear W21475263062023 @default.
• W2147526306 crossrefType "journal-article" @default.
• W2147526306 hasAuthorship W2147526306A5005132007 @default.
• W2147526306 hasAuthorship W2147526306A5007693230 @default.
• W2147526306 hasAuthorship W2147526306A5029685260 @default.
• W2147526306 hasAuthorship W2147526306A5041260468 @default.
• W2147526306 hasAuthorship W2147526306A5041953237 @default.
• W2147526306 hasAuthorship W2147526306A5068695724 @default.
• W2147526306 hasAuthorship W2147526306A5079018683 @default.
• W2147526306 hasConcept C104317684 @default.
• W2147526306 hasConcept C121608353 @default.
• W2147526306 hasConcept C126322002 @default.
• W2147526306 hasConcept C142724271 @default.
• W2147526306 hasConcept C145059251 @default.
• W2147526306 hasConcept C2777088508 @default.
• W2147526306 hasConcept C2778220009 @default.
• W2147526306 hasConcept C2779013556 @default.
• W2147526306 hasConcept C2779134260 @default.
• W2147526306 hasConcept C2779522080 @default.
• W2147526306 hasConcept C2779742232 @default.
• W2147526306 hasConcept C2780427987 @default.
• W2147526306 hasConcept C502942594 @default.
• W2147526306 hasConcept C54355233 @default.
• W2147526306 hasConcept C60644358 @default.
• W2147526306 hasConcept C71924100 @default.
• W2147526306 hasConcept C86803240 @default.
• W2147526306 hasConceptScore W2147526306C104317684 @default.
• W2147526306 hasConceptScore W2147526306C121608353 @default.
• W2147526306 hasConceptScore W2147526306C126322002 @default.
• W2147526306 hasConceptScore W2147526306C142724271 @default.
• W2147526306 hasConceptScore W2147526306C145059251 @default.
• W2147526306 hasConceptScore W2147526306C2777088508 @default.
• W2147526306 hasConceptScore W2147526306C2778220009 @default.
• W2147526306 hasConceptScore W2147526306C2779013556 @default.
• W2147526306 hasConceptScore W2147526306C2779134260 @default.
• W2147526306 hasConceptScore W2147526306C2779522080 @default.
• W2147526306 hasConceptScore W2147526306C2779742232 @default.
• W2147526306 hasConceptScore W2147526306C2780427987 @default.
• W2147526306 hasConceptScore W2147526306C502942594 @default.
• W2147526306 hasConceptScore W2147526306C54355233 @default.
• W2147526306 hasConceptScore W2147526306C60644358 @default.
• W2147526306 hasConceptScore W2147526306C71924100 @default.
• W2147526306 hasConceptScore W2147526306C86803240 @default.
• W2147526306 hasIssue "15" @default.
• W2147526306 hasLocation W21475263061 @default.
• W2147526306 hasLocation W21475263062 @default.
• W2147526306 hasOpenAccess W2147526306 @default.
• W2147526306 hasPrimaryLocation W21475263061 @default.
• W2147526306 hasRelatedWork W2042559265 @default.
• W2147526306 hasRelatedWork W2357773775 @default.
• W2147526306 hasRelatedWork W2417384042 @default.
• W2147526306 hasRelatedWork W2984941165 @default.
• W2147526306 hasRelatedWork W3114532332 @default.
• W2147526306 hasRelatedWork W3177941890 @default.
• W2147526306 hasRelatedWork W3182064091 @default.
• W2147526306 hasRelatedWork W4233453112 @default.
• W2147526306 hasRelatedWork W4256481120 @default.
• W2147526306 hasRelatedWork W4287073445 @default.
• W2147526306 hasVolume "19" @default.
• W2147526306 isParatext "false" @default.
• W2147526306 isRetracted "false" @default.
• W2147526306 magId "2147526306" @default.
• W2147526306 workType "article" @default.